Intratracheal Budesonide for BPD, Cell and Gene Therapy Access, Moderate Alcohol Consumption and Health, and more
JAMA Editors' Summary
00:00
Intratracheal Budesonide Does Not Reduce BPD or Death
Chris Muth summarizes the B.I. randomized trial showing budesonide plus surfactant did not lower bronchopulmonary dysplasia or death by 36 weeks.
Transcript
Play full episode
